{"nct_id":"NCT02832167","title":"An Open Label Investigational Immuno-therapy Trial of Nivolumab in Cancers That Are Advanced or Have Spread","status":"COMPLETED","status_verified_date":"2022-04","start_date":"2016-02-22","start_date_type":"ACTUAL","primary_completion_date":"2019-10-20","primary_completion_date_type":"ACTUAL","completion_date":"2021-06-24","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}